Menu
Search
|

Menu

Close
X

Divi's Laboratories Ltd DIVI.BO (Bombay Stock Exchange)

1,046.00 INR
+27.75 (+2.73%)
As of 1:27 PM IST
chart
Previous Close 1,018.25
Open 1,018.25
Volume 23,155
3m Avg Volume 77,305
Today’s High 1,050.20
Today’s Low 1,015.90
52 Week High 1,141.75
52 Week Low 533.10
Shares Outstanding (mil) 265.47
Market Capitalization (mil) 229,524.09
Forward P/E --
Dividend (Yield %) 10.00 ( 1.16 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.57 Mean rating from 14 analysts

KEY STATS

Revenue (mm, INR)
FY15
31,149
EPS (INR)
FY15
32.076
*Note: Units in Millions of Rupee
**Note: Units in Rupee

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.90
Price to Sales (TTM)
vs sector
--
5.77
Price to Book (MRQ)
vs sector
--
5.41
Price to Cash Flow (TTM)
vs sector
--
23.42
Total Debt to Equity (MRQ)
vs sector
--
16.52
LT Debt to Equity (MRQ)
vs sector
--
12.22
Return on Investment (TTM)
vs sector
--
14.43
Return on Equity (TTM)
vs sector
--
16.13

EXECUTIVE LEADERSHIP

Murali Divi
Executive Chairman of the Board, Managing Director, Since
Salary: Rs9,000,000.00
Bonus: --
L. Kishore Babu
Chief Financial Officer, Since 2010
Salary: --
Bonus: --
P. V. Lakshmi Rajani
Compliance Officer, Company Secretary, Since 2006
Salary: --
Bonus: --
Kiran Divi
Director & President - Operations, Executive Director, Since
Salary: Rs7,800,000.00
Bonus: --
Madhusudana Divi
Director - Projects, Executive Director, Since
Salary: Rs7,800,000.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

1-72/23(P)/Divis/303
, Divi Towers, Cyber Hills, Gach
HYDERABAD     500032

Phone: +9140.23786300

Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. The Company's geographical segments include India (Sales to customers within India) and other countries (Sales to customers outside India). Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids. It is also involved in developing alternate, non-infringing processes for APIs, for the inventors to manage late life cycle and generic drug manufacturers. The Company develops carotenoids, such as Apocarotenal, Betacarotene, Lycopene, Astaxanthin and Canthaxanthin. It manufactures tert-butoxycarbonyl (BOC), Fluorenylmethyloxycarbonyl (FMOC) and Carboxybenzyl (CBZ) protected amino acids. It manufactures ligands, such as binol and binap. The Company exports its products to European and the American countries. Its manufacturing and research and development facilities are located in the State of Andhra Pradesh and Telangana in India.

SPONSORED STORIES